Oncimmune Holdings (LSE:ONC) EV-to-EBITDA : -7.51 (As of Jun. 05, 2024)

Oncimmune Holdings EV-to-EBITDA Chart

Oncimmune Holdings Annual Data
	Trend	May14	May15	May16	May17	May18	May19	May20	May21	May22	Aug23
EV-to-EBITDA		Get a 7-Day Free Trial					-6.40	-8.27	-32.33	-10.60	-4.35

Oncimmune Holdings Semi-Annual Data
	May14	Nov14	May15	Nov15	May16	Nov16	May17	Nov17	May18	Nov18	May19	Nov19	May20	Nov20	May21	Nov21	May22	Feb23	Aug23	Feb24
EV-to-EBITDA	Get a 7-Day Free Trial															-	-10.60	-	-4.35	-

Competitive Comparison of Oncimmune Holdings's EV-to-EBITDA

For the Biotechnology subindustry, Oncimmune Holdings's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oncimmune Holdings's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oncimmune Holdings's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Oncimmune Holdings's EV-to-EBITDA falls into.

Oncimmune Holdings EV-to-EBITDA Calculation

Oncimmune Holdings's EV-to-EBITDA for today is calculated as:

Oncimmune Holdings's current Enterprise Value is £17.59 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Oncimmune Holdings's EBITDA for the trailing twelve months (TTM) ended in Feb. 2024 was £-2.34 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oncimmune Holdings  (LSE:ONC) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Oncimmune Holdings's PE Ratio for today is calculated as:

Oncimmune Holdings's share price for today is £0.1785.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Oncimmune Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Feb. 2024 was £0.110.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Oncimmune Holdings EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Oncimmune Holdings's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Oncimmune Holdings (LSE:ONC) Business Description